These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25983191)

  • 1. Rising to the challenge of multiple Cryptococcus species and the diseases they cause.
    Idnurm A; Lin X
    Fungal Genet Biol; 2015 May; 78():1-6. PubMed ID: 25983191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecules at the interface of Cryptococcus and the host that determine disease susceptibility.
    Wozniak KL; Olszewski MA; Wormley FL
    Fungal Genet Biol; 2015 May; 78():87-92. PubMed ID: 25445308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.
    Gibson JF; Johnston SA
    Fungal Genet Biol; 2015 May; 78():76-86. PubMed ID: 25498576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models for Inducing Experimental Cryptococcosis in Mice.
    Castro-Lopez N; Wormley FL
    Methods Mol Biol; 2024; 2775():29-46. PubMed ID: 38758309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal activity of
    Almeida-Apolonio AA; Dantas FGDS; Rodrigues AB; Cardoso CAL; Negri M; Oliveira KMP; Chang MR
    Nat Prod Res; 2019 Aug; 33(16):2363-2367. PubMed ID: 29463129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chronological history of the International Conference on Cryptococcus and Cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice.
    Kwon-Chung KJ; Perfect JR; Levitz SM
    Mycopathologia; 2012 Jun; 173(5-6):287-93. PubMed ID: 22038679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated Cryptococcus neoformans: case report and review of the literature.
    Patel NC; Ewanowski C; Kupiec-Banasikowska A; Hogan KP
    Cutis; 2009 Aug; 84(2):93-6. PubMed ID: 19746767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
    Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
    Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus and cryptococcosis in Cuba. A minireview.
    Illnait-Zaragozi MT; Martínez-Machín GF; Fernández-Andreu CM; Perurena-Lancha MR; Hagen F; Meis JF
    Mycoses; 2014 Dec; 57(12):707-17. PubMed ID: 25420448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten challenges on Cryptococcus and cryptococcosis.
    Del Poeta M; Casadevall A
    Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal therapies and drug targets: the old, the new and the promising.
    Coelho C; Casadevall A
    Cell Microbiol; 2016 Jun; 18(6):792-9. PubMed ID: 26990050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus neoformans: historical curiosity to modern pathogen.
    Srikanta D; Santiago-Tirado FH; Doering TL
    Yeast; 2014 Feb; 31(2):47-60. PubMed ID: 24375706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Cryptococcus and cryptococcosis in China.
    Fang W; Fa Z; Liao W
    Fungal Genet Biol; 2015 May; 78():7-15. PubMed ID: 25445309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs.
    Krysan DJ
    Fungal Genet Biol; 2015 May; 78():93-8. PubMed ID: 25514636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
    Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
    Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
    Gullo FP; Rossi SA; Sardi Jde C; Teodoro VL; Mendes-Giannini MJ; Fusco-Almeida AM
    Eur J Clin Microbiol Infect Dis; 2013 Nov; 32(11):1377-91. PubMed ID: 24141976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.